Literature DB >> 16310177

Fishing for prostanoids: deciphering the developmental functions of cyclooxygenase-derived prostaglandins.

Yong I Cha1, Lilianna Solnica-Krezel, Raymond N DuBois.   

Abstract

Prostaglandin G/H synthases (PGHS), commonly referred to as cyclooxygenases (COX-1 and COX-2), catalyze a key step in the synthesis of biologically active prostaglandins (PGs), the conversion of arachidonic acid (AA) into prostaglandin H(2) (PGH(2)). PGs have important functions in a variety of physiologic and pathologic settings, including inflammation, cardiovascular homeostasis, reproduction, and carcinogenesis. However, an evaluation of prostaglandin function in early development has been difficult due to the maternal contribution of prostaglandins from the uterus. The emergence of zebrafish as a model system has begun to provide some insights into the roles of this signaling cascade during vertebrate development. In zebrafish, COX-1 derived prostaglandins are required for two distinct stages of development, namely during gastrulation and segmentation. During gastrulation, PGE(2) signaling promotes cell motility, without altering the cell shape or directional migration of gastrulating cells. During segmentation, COX-1 signaling is also required for posterior mesoderm development, including the formation of vascular tube structures, angiogenesis of intersomitic vessels, and pronephros morphogenesis. We propose that deciphering the role for prostaglandin signaling in zebrafish development could yield insight and ultimately address the mechanistic details underlying various disease processes that result from perturbation of this pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16310177     DOI: 10.1016/j.ydbio.2005.10.013

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  37 in total

Review 1.  Evolutionary aspects of diet: the omega-6/omega-3 ratio and the brain.

Authors:  Artemis P Simopoulos
Journal:  Mol Neurobiol       Date:  2011-01-29       Impact factor: 5.590

2.  Cyclooxygenase-1-derived PGE2 promotes cell motility via the G-protein-coupled EP4 receptor during vertebrate gastrulation.

Authors:  Yong I Cha; Seok-Hyung Kim; Diane Sepich; F Gregory Buchanan; Lilianna Solnica-Krezel; Raymond N DuBois
Journal:  Genes Dev       Date:  2006-01-01       Impact factor: 11.361

3.  Prostaglandin signaling in ciliogenesis during development.

Authors:  Daqing Jin; Peiyun Liu; Tao P Zhong
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Celecoxib treatment of fibrous dysplasia (FD) in a human FD cell line and FD-like lesions in mice with protein kinase A (PKA) defects.

Authors:  Emmanouil Saloustros; Sisi Liu; Edward L Mertz; Nisan Bhattacharyya; Matthew F Starost; Paraskevi Salpea; Maria Nesterova; Michael Collins; Sergey Leikin; Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2016-08-04       Impact factor: 4.102

5.  Celecoxib reduces glucocorticoids in vitro and in a mouse model with adrenocortical hyperplasia.

Authors:  Sisi Liu; Emmanouil Saloustros; Annabel Berthon; Matthew F Starost; Isabelle Sahut-Barnola; Paraskevi Salpea; Eva Szarek; Fabio R Faucz; Antoine Martinez; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2015-10-05       Impact factor: 5.678

6.  Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) mediate cell density-dependent proinflammatory responses.

Authors:  Qiong Zhang; Xu Han; Jinfeng Chen; Xiaomei Xie; Jiafeng Xu; Yang Zhao; Jie Shen; Lin Hu; Pinglong Xu; Hai Song; Long Zhang; Bin Zhao; Ying-Jie Wang; Zongping Xia
Journal:  J Biol Chem       Date:  2018-10-12       Impact factor: 5.157

Review 7.  Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂.

Authors:  Jessica K Norberg; Earlphia Sells; Hui-Hua Chang; Srinivas R Alla; Shuxing Zhang; Emmanuelle J Meuillet
Journal:  Pharm Pat Anal       Date:  2013-03

8.  Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study.

Authors:  Sarah Kraus; Simone Hummler; Nadir Arber; Cornelia M Ulrich; Adetunji T Toriola; Elizabeth M Poole; Dominique Scherer; Jana Kotzmann; Karen W Makar; Dina Kazanov; Lior Galazan; Inna Naumov; Anna E Coghill; David Duggan; Biljana Gigic
Journal:  Pharmacogenet Genomics       Date:  2013-08       Impact factor: 2.089

9.  15-oxo-Eicosatetraenoic acid, a metabolite of macrophage 15-hydroxyprostaglandin dehydrogenase that inhibits endothelial cell proliferation.

Authors:  Cong Wei; Peijuan Zhu; Sumit J Shah; Ian A Blair
Journal:  Mol Pharmacol       Date:  2009-06-17       Impact factor: 4.436

10.  Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition.

Authors:  Heather L Chandler; Curtis A Barden; Ping Lu; Donna F Kusewitt; Carmen M H Colitz
Journal:  Mol Vis       Date:  2007-04-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.